| __timestamp | Takeda Pharmaceutical Company Limited | Telix Pharmaceuticals Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 520990000000 | 22622695 |
| Thursday, January 1, 2015 | 535405000000 | 24863028 |
| Friday, January 1, 2016 | 558755000000 | 21351001 |
| Sunday, January 1, 2017 | 495921000000 | 53837297 |
| Monday, January 1, 2018 | 659690000000 | 16080096 |
| Tuesday, January 1, 2019 | 1089764000000 | 18525736 |
| Wednesday, January 1, 2020 | 994308000000 | 2024000 |
| Friday, January 1, 2021 | 1106846000000 | 2548000 |
| Saturday, January 1, 2022 | 1244072000000 | 61556000 |
| Sunday, January 1, 2023 | 1431505000000 | 188157000 |
| Monday, January 1, 2024 | 1431505000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Takeda Pharmaceutical Company Limited, a Japanese multinational, and Telix Pharmaceuticals Limited, an Australian biotech firm, present a fascinating contrast in cost of revenue trends from 2014 to 2023. Takeda's cost of revenue has surged by approximately 175% over this period, peaking at 1.43 trillion in 2023. This reflects its expansive global operations and diverse product portfolio. In contrast, Telix, a relatively new player, shows a more modest increase, with its cost of revenue reaching 188 million in 2023, a significant leap from its earlier figures. This disparity highlights the scale and operational differences between established giants and emerging innovators. Notably, data for 2024 is incomplete, indicating potential shifts in the coming years. This comparison underscores the diverse strategies and challenges faced by pharmaceutical companies in managing costs.
Comparing Cost of Revenue Efficiency: Merck & Co., Inc. vs Telix Pharmaceuticals Limited
Cost of Revenue Comparison: Pfizer Inc. vs Takeda Pharmaceutical Company Limited
Cost of Revenue: Key Insights for Pfizer Inc. and Telix Pharmaceuticals Limited
Cost of Revenue: Key Insights for Vertex Pharmaceuticals Incorporated and Telix Pharmaceuticals Limited
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Exelixis, Inc.
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Amneal Pharmaceuticals, Inc.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Telix Pharmaceuticals Limited's Expenses
Cost of Revenue: Key Insights for Insmed Incorporated and Telix Pharmaceuticals Limited
Analyzing Cost of Revenue: Walgreens Boots Alliance, Inc. and Telix Pharmaceuticals Limited
Comparing Cost of Revenue Efficiency: Telix Pharmaceuticals Limited vs ACADIA Pharmaceuticals Inc.